Mal Jarmolowicz joins OPSL as CEO
Mal Jarmolowicz, CEO
Bringing a plethora of relevant experience, Mal Jarmolowicz has recently joined as CEO of OPSL. With experience across both large Pharma with Degussa Pharmaceuticals & Glaxo Wellcome and Medical Technology start-ups where she has held Board level positions since 2000. Mal was CEO of Celltran Ltd for six years, launching two ATMPs and acquiring Belgium based Xcellentis.
Mal is responsible for the direction and strategy of the company.